A Dutch health insurer is proposing to expand coverage for weight-loss medications to a broader group of patients, but family doctors are pushing back, saying they cannot take on the responsibility.
The initiative, reported by EenVandaag, aims to develop obesity treatments more accessible through public reimbursement. However, general practitioners have expressed concerns about their capacity to manage prescribing and monitoring these drugs safely.
Doctors argue that without additional support, training, or resources, overseeing long-term use of weight-loss medications falls outside their current scope of practice. They emphasize that such decisions require specialized knowledge and follow-up that many primary care clinics are not equipped to provide.
The debate highlights growing tensions between efforts to address obesity as a public health issue and the practical limitations faced by frontline healthcare providers. While expanding access to effective treatments could improve health outcomes for many, physicians stress that systemic changes are needed before they can safely participate in such programs.
For now, the insurer’s proposal remains under discussion, with no changes to current reimbursement policies announced.
